Intravenous Iron Versus Erythropoiesis-Stimulating Agents: Friends or Foes in Treating Chronic Kidney Disease Anemia?
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference57 articles.
1. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin;Eschbach;N Engl J Med,1989
2. Anemia of chronic kidney disease;Singh;Clin J Am Soc Nephrol,2008
3. Medicare and erythropoietin;Steinbrook;N Engl J Med,2007
4. Anemia of chronic disease;Weiss;N Engl J Med,2005
5. Iron requirements in erythropoietin therapy;Eschbach;Best Pract Res Clin Haematol,2005
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in mice;International Immunopharmacology;2024-12
2. Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients;Journal of International Medical Research;2023-10
3. Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial);Scientific Reports;2023-01-23
4. Intravenous iron sucrose is safe but does not prevent development of anemia or iron deficiency in healthy cats undergoing serial venipuncture;American Journal of Veterinary Research;2022-05-08
5. Efficacy and Safety of Daprodustat Vs rhEPO for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis;Frontiers in Pharmacology;2022-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3